Imaging alternatives to colonoscopy: CT colonography and colon capsule. European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline - Update 2020.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 27 10 2020
medline: 16 4 2021
entrez: 26 10 2020
Statut: ppublish

Résumé

1. ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. Strong recommendation, high quality evidence. ESGE/ESGAR do not recommend barium enema in this setting. Strong recommendation, high quality evidence.2. ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. The timing depends on an interdisciplinary decision including endoscopic and radiological factors. Strong recommendation, low quality evidence. ESGE/ESGAR suggests that, in centers with expertise in and availability of colon capsule endoscopy (CCE), CCE preferably the same or the next day may be considered if colonoscopy is incomplete. Weak recommendation, low quality evidence.3. When colonoscopy is contraindicated or not possible, ESGE/ESGAR recommend CTC as an acceptable and equally sensitive alternative for patients with alarm symptoms. Strong recommendation, high quality evidence. Because of lack of direct evidence, ESGE/ESGAR do not recommend CCE in this situation. Very low quality evidence. ESGE/ESGAR recommend CTC as an acceptable alternative to colonoscopy for patients with non-alarm symptoms. Strong recommendation, high quality evidence. In centers with availability, ESGE/ESGAR suggests that CCE may be considered in patients with non-alarm symptoms. Weak recommendation, low quality evidence.4. Where there is no organized fecal immunochemical test (FIT)-based population colorectal screening program, ESGE/ESGAR recommend CTC as an option for colorectal cancer screening, providing the screenee is adequately informed about test characteristics, benefits, and risks, and depending on local service- and patient-related factors. Strong recommendation, high quality evidence. ESGE/ESGAR do not suggest CCE as a first-line screening test for colorectal cancer. Weak recommendation, low quality evidence.5. ESGE/ESGAR recommend CTC in the case of a positive fecal occult blood test (FOBT) or FIT with incomplete or unfeasible colonoscopy, within organized population screening programs. Strong recommendation, moderate quality evidence. ESGE/ESGAR also suggest the use of CCE in this setting based on availability. Weak recommendation, moderate quality evidence.6. ESGE/ESGAR suggest CTC with intravenous contrast medium injection for surveillance after curative-intent resection of colorectal cancer only in patients in whom colonoscopy is contraindicated or unfeasible. Weak recommendation, low quality evidence. There is insufficient evidence to recommend CCE in this setting. Very low quality evidence.7. ESGE/ESGAR suggest CTC in patients with high risk polyps undergoing surveillance after polypectomy only when colonoscopy is unfeasible. Weak recommendation, low quality evidence. There is insufficient evidence to recommend CCE in post-polypectomy surveillance. Very low quality evidence.8. ESGE/ESGAR recommend against CTC in patients with acute colonic inflammation and in those who have recently undergone colorectal surgery, pending a multidisciplinary evaluation. Strong recommendation, low quality evidence.9. ESGE/ESGAR recommend referral for endoscopic polypectomy in patients with at least one polyp ≥6 mm detected at CTC or CCE. Follow-up CTC may be clinically considered for 6-9-mm CTC-detected lesions if patients do not undergo polypectomy because of patient choice, comorbidity, and/or low risk profile for advanced neoplasia. Strong recommendation, moderate quality evidence. Source and scope This is an update of the 2014-15 Guideline of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). It addresses the clinical indications for the use of imaging alternatives to standard colonoscopy. A targeted literature search was performed to evaluate the evidence supporting the use of computed tomographic colonography (CTC) or colon capsule endoscopy (CCE). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence.

Identifiants

pubmed: 33104846
doi: 10.1007/s00330-020-07413-4
pii: 10.1007/s00330-020-07413-4
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2967-2982

Références

Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
pubmed: 30207593 pmcid: 30207593
Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329:1977–1981
pubmed: 8247072
Brenner H, Chang-Claude J, Jansen L et al (2014) Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 146:709–717
pubmed: 24012982
Zauber AG, Winawer SJ, O’Brien MJ et al (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696
pubmed: 22356322 pmcid: 3322371
Rex DK, Boland CR, Dominitz JA et al (2017) Colorectal cancer screening: recommendations for physicians and patients from the U.S multi-society task force on colorectal cancer. Am J Gastroenterol 112:1016–1030
pubmed: 28555630
Doubeni CA, Weinmann S, Adams K et al (2013) Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 158(5 Pt 1):312–320
pubmed: 23460054 pmcid: 3752391
Khalid-de Bakker C, Jonkers D, Smits K et al (2011) Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy 43:1059–1086
pubmed: 22135196
Vining D, Galfand D, Bechtold R (1994) Technical feasibility of colon imaging with helical CT and virtual reality [abstract]. AJR Am J Roentgenol 162:104
Neri E, Halligan S, Hellström M et al (2013) The second ESGAR consensus statement on CT colonography. Eur Radiol 23:720–729
pubmed: 22983280
Eliakim R, Fireman Z, Gralnek IM et al (2006) Evaluation of the PillCam Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy 38:963–970
pubmed: 17058158
Spada C, Stoker J, Alarcon O et al (2015) Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guideline. Eur Radiol 25:331–345
pubmed: 25278245
Spada C, Hassan C, Galmiche JP et al (2012) Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 44:527–536
pubmed: 22389230
Richardson WS, Wilson MC, Nishikawa J et al (1995) The well-built clinical question: a key to evidence-based decisions. ACP J Club 123:A12–A13
pubmed: 7582737
Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926
pubmed: 18436948 pmcid: 18436948
Atkins D, Best D, Briss PA et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490. https://doi.org/10.1136/bmj.328.7454.1490
doi: 10.1136/bmj.328.7454.1490 pubmed: 15205295
Dumonceau J-M, Hassan C, Riphaus A et al (2012) European Society of Gastrointestinal Endoscopy (ESGE) guideline development policy. Endoscopy 44:626–629
pubmed: 22370700
Sali L, Mascalchi M, Falchini M et al (2015) Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial. J Natl Cancer Inst 108:djv319
pubmed: 26719225
Regge D, Iussich G, Segnan N et al (2017) Comparing CT colonography and flexible sigmoidoscopy: a randomised trial within a population-based screening programme. Gut 66:1434–1440
pubmed: 27196588
Nolthenius CJT, Boellaard TN, de Haan MC et al (2015) Evolution of screen-detected small (6–9 mm) polyps after a 3-year surveillance interval: assessment of growth with CT colonography compared with histopathology. A J Gastroenterol 110:1682–1690
Obaro AE, Plumb AA, Fanshawe TR et al (2018) Post-imaging colorectal cancer or interval cancer rates after CT colonography: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 3:326–336
pubmed: 29472116
Nagata K, Endo S, Honda T et al (2017) Accuracy of CT colonography for detection of polypoid and non-polypoid neoplasia by gastroenterologists and radiologists: a nationwide multicenter study in Japan. Am J Gastroenterol 112:163–171
pubmed: 27779195
Halligan S, Dadswell E, Wooldrage K et al (2015) Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicenter randomised trials with economic evaluation (the SIGGAR trials). Health Technol Assess 19:1–134
pubmed: 26198205 pmcid: 4781284
Maaser C, Sturm A, Vavricka SR et al (2019) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13:144–164
pubmed: 30137275
Flor N, Mezzanzanica M, Rigamonti P et al (2013) Contrast-enhanced computed tomography colonography in preoperative distinction between T1-T2 and T3-T4 staging of colon cancer. Acad Radiol 20:590–595
pubmed: 23477825
Horvat N, Raj A, Ward JM et al (2018) Clinical value of CT colonography versus preoperative colonoscopy in the surgical management of occlusive colorectal cancer. AJR Am J Roentgenol 210:333–340
pubmed: 29261351
Flor N, Zanchetta E, Di Leo G et al (2018) Synchronous colorectal cancer using CT colonography vs. other means: a systematic review and meta-analysis. Abdom Radiol 43:3241–3249
Atkin W, Dadswell E, Wooldrage K et al (2013) Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet 381:1194–1202
pubmed: 23414650
Poston GJ, Tait D, O’Connell S et al (2011) Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ 343:d6751–d6751
pubmed: 22074710
O’Shea A, Foran A, Murray T et al (2020) Quality of same day CT colonography following incomplete optical colonoscopy. Eur Radiol. https://doi.org/10.1007/s00330-020-06979-3
Chang KJ, Rekhi SS, Anderson SW et al (2011) Fluid tagging for CT colonography: effectiveness of a 2-hour iodinated oral preparation after incomplete optical colonoscopy. J Comput Assist Tomogr 35:91–95
pubmed: 21160430
Theis J, Kim DH, Lubner MG et al. CT colonography after incomplete optical colonoscopy: bowel preparation quality at same-day vs. deferred examination. Abdom Radiol (NY) 2016; 41: 10–18
Saluja S, Gaikstas G, Sapundzieski M (2017) Optimal timing for faecal tagging in same day CT colonography for patients with failed colonoscopy. Radiography (Lond) 23:e47–e49
O’Shea A, Murray T, Morrin MM et al (2020) Incidence of clinically significant perforation at low dose non-contrast CT and its value prior to same day CT colonography following incomplete colonoscopy. Abdom Radiol (NY) 45:1044–1048
Lara LF, Avalos D, Huynh H et al (2015) The safety of same-day CT colonography following incomplete colonoscopy with polypectomy. United European Gastroenterol J 3:358–363
pubmed: 26279844 pmcid: 4528210
Baltes P, Bota M, Albert J et al (2018) PillCamColon2 after incomplete colonoscopy - a prospective multicenter study. World J Gastroenterol 24:3556–3566
pubmed: 30131662 pmcid: 6102503
Hussey M, Holleran G, Stack R et al (2018) Same-day colon capsule endoscopy is a viable means to assess unexplored colonic segments after incomplete colonoscopy in selected patients. United European Gastroenterol J 6:1556–1562
pubmed: 30574326 pmcid: 6297922
Nogales Ó, García-Lledó J, Luján M et al (2017) Therapeutic impact of colon capsule endoscopy with PillCam™ COLON 2 after incomplete standard colonoscopy: a Spanish multicenter study. Rev Esp Enferm Dig 109:322–327
pubmed: 28229607
Toth E, Yung DE, Nemeth A et al (2017) Video capsule colonoscopy in routine clinical practice. Ann Transl Med 5:195–195
pubmed: 28567375 pmcid: 5438790
Spada C, Hassan C, Barbaro B et al (2015) Colon capsule versus CT colonography in patients with incomplete colonoscopy: a prospective, comparative trial. Gut. 64:272–281
pubmed: 24964317
Negreanu L, Smarandache G, Mateescu RB (2014) Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn’s disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series. Tech Coloproctol 18:277–283
pubmed: 23963837
Negreanu L, Babiuc R, Bengus A et al (2013) PillCam Colon 2 capsule in patients unable or unwilling to undergo colonoscopy. World J Gastrointest Endosc 5:559–567
pubmed: 24255748 pmcid: 3831198
Triantafyllou K, Viazis N, Tsibouris P et al (2014) Colon capsule endoscopy is feasible to perform after incomplete colonoscopy and guides further workup in clinical practice. Gastrointest Endosc 79:307–316
pubmed: 24060522
Alarcón-Fernández O, Ramos L, Adrián-de-Ganzo Z et al (2013) Effects of colon capsule endoscopy on medical decision making in patients with incomplete colonoscopies. Clin Gastroenterol Hepatol 11:534–540.e1
pubmed: 23078891
Pioche M, de Leusse A, Filoche B et al (2012) Prospective multicenter evaluation of colon capsule examination indicated by colonoscopy failure or anesthesia contraindication. Endoscopy 44:911–916
pubmed: 22893133
Jellema P, van der Windt DAWM, Bruinvels DJ et al (2010) Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 340:c1269
pubmed: 20360221 pmcid: 2848719
Pickhardt PJ, Correale L, Delsanto S et al (2018) CT colonography performance for the detection of polyps and cancer in adults ≥65 years old: systematic review and meta-analysis. AJR Am J Roentgenol 211:40–51
pubmed: 29667892
Pickhardt PJ, Correale L, Morra L et al (2018) Extracolonic findings at CT colonography: systematic review and meta-analysis. AJR Am J Roentgenol 211:25–39
pubmed: 29792744
Halligan S, Wooldrage K, Dadswell E et al (2015) Identification of extracolonic pathologies by computed tomographic colonography in colorectal cancer symptomatic patients. Gastroenterology 149:89–101.e5
pubmed: 25796362
Cha JM, Kozarek RA, La Selva D et al (2016) Risks and benefits of colonoscopy in patients 90 years or older, compared with younger patients. Clin Gastroenterol Hepatol 14:80–86.e1
pubmed: 26164224
Stoop EM, de Haan MC, de Wijkerslooth TR et al (2012) Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 13:55–64
pubmed: 22088831
Sali L, Regge D (2016) CT colonography for population screening of colorectal cancer: hints from European trials. Br J Radiol 89:20160517
pubmed: 27542076 pmcid: 5604916
Senore C, Correale L, Regge D et al (2018) Flexible sigmoidoscopy and CT colonography screening: patients’ experience with and factors for undergoing screening-insight from the PROTEUS colon trial. Radiology 286:873–883
pubmed: 29040021
Tutein Nolthenius CJ, Boellaard TN, de Haan MC et al (2016) Computer tomography colonography participation and yield in patients under surveillance for 6–9 mm polyps in a population-based screening trial. Eur Radiol 26:2762–2770
pubmed: 26560732
Leggett B, Whitehall V (2010) Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138:2088–2100
pubmed: 20420948
Sali L, Ventura L, Grazzini G et al (2019) Patients’ experience of screening CT colonography with reduced and full bowel preparation in a randomised trial. Eur Radiol 29:2457–2464
pubmed: 30402705
Pendsé DA, Taylor SA (2013) Complications of CT colonography: a review. Eur J Radiol 82:1159–1165
pubmed: 22595505
Plumb AA, Ghanouni A, Rees CJ et al (2017) Patient experience of CT colonography and colonoscopy after fecal occult blood test in a national screening programme. Eur Radiol 27:1052–1063
pubmed: 27287477
Nagata K, Takabayashi K, Yasuda T et al (2017) Adverse events during CT colonography for screening, diagnosis and preoperative staging of colorectal cancer: a Japanese national survey. Eur Radiol 27:4970–4978
pubmed: 28674967
Bellini D, Rengo M, De Cecco CN et al (2014) Perforation rate in CT colonography: a systematic review of the literature and meta-analysis. Eur Radiol 24:1487–1496
pubmed: 24816935
Holme Ø, Bretthauer M, Fretheim A et al (2013) Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 9:CD009259
Kang H-J, Kim SH, Shin C-I et al (2018) Sub-millisievert CT colonography: effect of knowledge-based iterative reconstruction on the detection of colonic polyps. Eur Radiol 28:5258–5266
pubmed: 29948063
Chin M, Mendelson R, Edwards J et al (2005) Computed tomographic colonography: prevalence, nature, and clinical significance of extracolonic findings in a community screening program. Am J Gastroenterol 100:2771–2776
pubmed: 16393234
Veerappan GR, Ally MR, Choi J-HR et al (2010) Extracolonic findings on CT colonography increases yield of colorectal cancer screening. AJR Am J Roentgenol 195:677–686
pubmed: 20729446
Kim YS, Kim N, Kim SY et al (2008) Extracolonic findings in an asymptomatic screening population undergoing intravenous contrast-enhanced computed tomography colonography. J Gastroenterol Hepatol 23(7 Pt 2):e49–e57
pubmed: 17645481
de Haan MC, Thomeer M, Stoker J et al (2013) Unit costs in population-based colorectal cancer screening using CT colonography performed in university hospitals in the Netherlands. Eur Radiol 23:897–907
pubmed: 23138383
Mantellini P, Lippi G, Sali L et al (2018) Cost analysis of colorectal cancer screening with CT colonography in Italy. Eur J Health Econ 19:735–746
pubmed: 28681075
van der Meulen MP, Lansdorp-Vogelaar I, Goede SL et al (2018) Colorectal cancer: cost-effectiveness of colonoscopy versus CT colonography screening with participation rates and costs. Radiology 287:901–911
pubmed: 29485322 pmcid: 6716164
Ran T, Cheng C-Y, Misselwitz B et al (2019) Cost-effectiveness of colorectal cancer screening strategies – a systematic review. Clin Gastroenterol Hepatol 17:1969–1981.e15
pubmed: 30659991
Kobaek-Larsen M, Kroijer R, Dyrvig A-K et al (2018) Back-to-back colon capsule endoscopy and optical colonoscopy in colorectal cancer screening individuals. Color Dis 20:479–485
Pioche M, Ganne C, Gincul R et al (2018) Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial. Endoscopy 50:761–769
pubmed: 29486502
Thygesen MK, Baatrup G, Petersen C et al (2019) Screening individuals’ experiences of colonoscopy and colon capsule endoscopy; a mixed methods study. Acta Oncol 58(sup1):S71–S76
pubmed: 30821625
Rex DK, Adler SN, Aisenberg J et al (2015) Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 148:948–957.e2
pubmed: 25620668
Cash BD, Fleisher MR, Fern S et al (2019) A multicenter, prospective, randomized study comparing the diagnostic yield of colon capsule endoscopy versus computed tomographic colonography in a screening population. Results of the TOPAZ study. Gastrointest Endosc 89:AB87–AB88
Parodi A, Vanbiervliet G, Hassan C et al (2018) Colon capsule endoscopy to screen for colorectal neoplasia in those with family histories of colorectal cancer. Gastrointest Endosc 87:695–704
pubmed: 28554656
Adrián-de-Ganzo Z, Alarcón-Fernández O, Ramos L et al (2015) Uptake of colon capsule endoscopy vs colonoscopy for screening relatives of patients with colorectal cancer. Clin Gastroenterol Hepatol 13:2293–2301.e1
pubmed: 26133904
Plumb AA, Halligan S, Pendsé DA et al (2014) Sensitivity and specificity of CT colonography for the detection of colonic neoplasia after positive faecal occult blood testing: systematic review and meta-analysis. Eur Radiol 24:1049–1058
pubmed: 24519111
Rondonotti E, Borghi C, Mandelli G et al (2014) Accuracy of capsule colonoscopy and computed tomographic colonography in individuals with positive results from the fecal occult blood test. Clin Gastroenterol Hepatol 12:1303–1310
pubmed: 24398064
Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG et al (2009) At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer 124:1161–1168
pubmed: 19048626 pmcid: 2859672
Sali L, Grazzini G, Ventura L et al (2013) Computed tomographic colonography in subjects with positive faecal occult blood test refusing optical colonoscopy. Dig Liver Dis 45:285–289
pubmed: 23266193
Plumb AA, Halligan S, Nickerson C et al (2014) Use of CT colonography in the English bowel Cancer screening Programme. Gut 63:964–973
pubmed: 23955527
Derbyshire E, Hungin P, Nickerson C et al (2018) Colonoscopic perforations in the English national health service bowel Cancer screening Programme. Endoscopy 50:861–870
pubmed: 29590669
Holleran G, Leen R, O’Morain C et al (2014) Colon capsule endoscopy as possible filter test for colonoscopy selection in a screening population with positive fecal immunology. Endoscopy 46:473–478
pubmed: 24824091
Pecere S, Senore C, Hassan C et al (2020) Accuracy of colon capsule endoscopy for advanced neoplasia. Gastrointest Endosc 91:406–414.e1
pubmed: 31629719
Porté F, Uppara M, Malietzis G et al (2017) CT colonography for surveillance of patients with colorectal cancer: systematic review and meta-analysis of diagnostic efficacy. Eur Radiol 27:51–60
pubmed: 26993649
Amitai MM, Fidder H, Avidan B et al (2009) Contrast-enhanced CT colonography with 64-slice MDCT compared to endoscopic colonoscopy in the follow-up of patients after colorectal cancer resection. Clin Imaging 33:433–438
pubmed: 19857803
Kim HJ, Park SH, Pickhardt PJ et al (2010) CT colonography for combined colonic and extracolonic surveillance after curative resection of colorectal cancer. Radiology 257:697–704
pubmed: 20876390
Neri E, Vagli P, Turini F et al (2010) Post-surgical follow-up of colorectal cancer: role of contrast-enhanced CT colonography. Abdom Imaging 35:669–675
pubmed: 20033808
Weinberg DS, Pickhardt PJ, Bruining DH et al (2018) Computed tomography colonography vs colonoscopy for colorectal cancer surveillance after surgery. Gastroenterology 154:927–934.e4
pubmed: 29174927
Weinberg DS, Mitnick J, Keenan E et al (2019) Post-operative colorectal cancer surveillance: preference for optical colonoscopy over computerized tomographic colonography. Cancer Causes Control 30:1269–1273
pubmed: 31531798 pmcid: 7534185
Beck JR, Ross EA, Kuntz KM et al (2018) Yield and cost-effectiveness of computed tomography colonography versus colonoscopy for post colorectal cancer surveillance. MDM Policy Pract 3:238146831881051
Hassan C, Quintero E, Dumonceau J-M et al (2013) Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 45:842–864
pubmed: 24030244
Colquhoun P, Chen H-C, Kim JI et al (2004) High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up. Color Dis 6:158–161
Taylor DP, Cannon-Albright LA, Sweeney C et al (2011) Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med 13:737–743
pubmed: 21555945
Rapuri S, Spencer J, Eckels D (2008) Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening – review of literature. Int J Color Dis 23:453–459
Cooper GS, Kou TD, Barnholtz Sloan JS et al (2013) Use of colonoscopy for polyp surveillance in Medicare beneficiaries. Cancer 119:1800–1807
pubmed: 23436321 pmcid: 3648624
Koh FH, Chan DKH, Ng J et al (2019) Adherence to surveillance guidelines following colonic polypectomy is abysmal. J Gastrointest Oncol 10:166–170
pubmed: 31032081 pmcid: 6465487
Atkin W, Cross AJ, Kralj-Hans I et al (2019) Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Health Technol Assess 23:1–84
pubmed: 30618357 pmcid: 6340104
Regge D, Laudi C, Galatola G et al (2009) Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. JAMA 301:2453–2461
pubmed: 19531785
Sosna J, Sella T, Sy O et al (2008) Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps > or = 6 mm in the era of CT colonography. AJR Am J Roentgenol 190:374–385
pubmed: 18212223
Kroijer R, Kobaek-Larsen M, Qvist N et al (2019) Colon capsule endoscopy for colonic surveillance. Color Dis 21:532–537
Burling D, Halligan S, Slater A et al (2006) Potentially serious adverse events at CT colonography in symptomatic patients: national survey of the United Kingdom. Radiology 239:464–471
pubmed: 16569789
Pickhardt PJ (2006) Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults. Radiology 239:313–316
pubmed: 16641348
Prabhakar N, Kalra N, Bhasin DK et al (2015) Comparison of CT colonography with conventional colonoscopy in patients with ulcerative colitis. Acad Radiol 22:296–302
pubmed: 25435187
Silvestre J, del Mar Sánchez-Lauro M, del Mar Callejón M et al (2015) Pneumoperitoneum after CT colonography in a patient with ulcerative colitis. Rev Esp Enferm Dig 107:456–457
pubmed: 26140645
Zafar HM, Harhay MO, Yang J et al (2014) Adverse events following computed tomographic colonography compared to optical colonoscopy in the elderly. Prev Med Rep 1:3–8
pubmed: 25530940 pmcid: 4266938
Ponugoti PL, Cummings OW, Rex DK (2017) Risk of cancer in small and diminutive colorectal polyps. Dig Liver Dis 49:34–37
pubmed: 27443490
Hassan C, Pickhardt PJ, Kim DH et al (2010) Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther 31:210–217
pubmed: 19814745
Lieberman D, Moravec M, Holub J et al (2008) Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology 135:1100–1105
pubmed: 18691580 pmcid: 2581902
Hassan C, Pooler BD, Kim DH et al (2013) Computed tomographic colonography for colorectal cancer screening: risk factors for the detection of advanced neoplasia. Cancer 119:2549–2554
pubmed: 23754679 pmcid: 3700619
Kolligs FT, Crispin A, Graser A et al (2013) Risk factors for advanced neoplasia within subcentimetric polyps: implications for diagnostic imaging. Gut 62:863–870
pubmed: 22525884
Pickhardt PJ, Kim DH, Pooler BD et al (2013) Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol 14:711–720
pubmed: 23746988 pmcid: 4018232
Pooler BD, Kim DH, Weiss JM et al (2016) Colorectal polyps missed with optical colonoscopy despite previous detection and localization with CT colonography. Radiology 278:422–429
pubmed: 26280354
Bond JH (2001) Clinical relevance of the small colorectal polyp. Endoscopy 33:454–457
pubmed: 11396767
Church JM (2004) Clinical significance of small colorectal polyps. Dis Colon Rectum 47:481–485
pubmed: 14994108
Weston AP, Campbell DR (1995) Diminutive colonic polyps: histopathology, spatial distribution, concomitant significant lesions, and treatment complications. Am J Gastroenterol 90:24–28
pubmed: 7801943
van Rijn JC, Reitsma JB, Stoker J et al (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101:343–350
pubmed: 16454841
Rex DK, Cutler CS, Lemmel GT et al (1997) Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112:24–28
pubmed: 8978338
Spada C, Hassan C, Galmiche JP et al (2012) Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 44:527–536
pubmed: 22389230
Martínez ME, Baron JA, Lieberman DA et al (2009) A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136:832–841
pubmed: 19171141

Auteurs

Cristiano Spada (C)

Digestive Endoscopy Unit and Gastronenterology, Fondazione Poliambulanza, Brescia, Italy. cristianospada@gmail.com.
Department of Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. cristianospada@gmail.com.

Cesare Hassan (C)

Gastroenterology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.

Davide Bellini (D)

Department of Radiological Sciences, Oncology and Pathology, Diagnostic Imaging Unit, La Sapienza University of Rome, I.C.O.T. Hospital, Latina, Italy.

David Burling (D)

St. Mark's Hospital, Harrow, London, UK.

Giovanni Cappello (G)

Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.

Cristina Carretero (C)

Department of Gastroenterology, University of Navarre Clinic, Healthcare Research Institute of Navarre, Pamplona, Spain.

Evelien Dekker (E)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center location AMC, Amsterdam, The Netherlands.

Rami Eliakim (R)

Department of Gastroenterology, Sheba Medical Center, Sackler School of Medicine, Tel-Aviv, Israel.

Margriet de Haan (M)

Department of Radiology, University Medical Center, Utrecht, The Netherlands.

Michal F Kaminski (MF)

Departments of Gastroenterological Oncology and Cancer Prevention, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Anastasios Koulaouzidis (A)

Endoscopy Unit, Centre for Liver and Digestive Disorders, University Hospitals, NHS Lothian, Edinburgh, UK.

Andrea Laghi (A)

Department of Surgical-Medical Sciences and Translational Medicine, La Sapienza University of Rome, Rome, Italy.

Philippe Lefere (P)

Department of Radiology, Stedelijk Ziekenhuis, Roeselare, Belgium.

Thomas Mang (T)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Sebastian Manuel Milluzzo (SM)

Digestive Endoscopy Unit and Gastronenterology, Fondazione Poliambulanza, Brescia, Italy.
Department of Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Martina Morrin (M)

RCSI Radiology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Deirdre McNamara (D)

TAGG Research Centre, Department of Clinical Medicine, Trinity Centre, Tallaght Hospital, Dublin, Ireland.

Emanuele Neri (E)

Diagnostic Radiology 3, Department of Translational Research, University of Pisa, Pisa, Italy.

Silvia Pecere (S)

Department of Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Mathieu Pioche (M)

Endoscopy and Gastroenterology Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

Andrew Plumb (A)

Centre for Medical Imaging, University College London, London, UK.

Emanuele Rondonotti (E)

Gastroenterology Unit, Ospedale Valduce, Como, Italy.

Manon Cw Spaander (MC)

Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Stuart Taylor (S)

Centre for Medical Imaging, University College London, London, UK.

Ignacio Fernandez-Urien (I)

Gastroenterology, Hospital de Navarra, Pamplona, Spain.

Jeanin E van Hooft (JE)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Jaap Stoker (J)

Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Daniele Regge (D)

Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
University of Turin Medical School, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH